Amsterdam is a world leader in life sciences and health. The city thrives on cooperation, driven by the concentration of its many research institutions, universities, established corporations and startups. The sector also has a close relationship with technology. They collaborate and form partnerships in specialised hubs, including Amsterdam Science Park, the Amsterdam Life Sciences District, the Knowledge Quarter VU/Zuidas and the NKI.
Benefits from the Netherlands #1 ranking in the Global Connectedness Index 2018
Features an innovative research, business and learning hub at Amsterdam Science Park
One of the world’s top 5 tech cities with the highest level of broadband penetration
Has a talented academic community and two dedicated science faculties
Home to a growing community of over 300 life sciences companies
Offers a multilingual, highly-skilled workforce
The Belgian-Dutch biotech company Galapagos has signed a research deal worth $5.1 billion (€4.5 billion) with pharma giant Gilead.
The US pharma company Colorcon is going to build a production facility in Almere.
The HealthInc accelerator aims to foster relationships between cutting-edge startups and scale-ups and major players in the health and business sectors to bring new innovations to the market and improve patient care.